143 related articles for article (PubMed ID: 37942495)
1. Transperineal laser ablation (TPLA) with ultrasound/MRI fusion guidance in the treatment of localized radiotherapy-resistant prostate cancer.
Manenti G; Nezzo M; Ryan CP; Fraioli FR; Carreri B; Gigliotti PE; Angeloni C; Di Pietro F; De Angeli M; Perretta T; D'Angelillo RM; Garaci FG
BJR Open; 2023; 5(1):20230042. PubMed ID: 37942495
[TBL] [Abstract][Full Text] [Related]
2. Transperineal Laser Ablation (TPLA) Treatment of Focal Low-Intermediate Risk Prostate Cancer.
Manenti G; Perretta T; Nezzo M; Fraioli FR; Carreri B; Gigliotti PE; Micillo A; Malizia A; Di Giovanni D; Ryan CP; Garaci FG
Cancers (Basel); 2024 Apr; 16(7):. PubMed ID: 38611082
[No Abstract] [Full Text] [Related]
3. Reliable Visualization of the Treatment Effect of Transperineal Focal Laser Ablation in Prostate Cancer Patients by Magnetic Resonance Imaging and Contrast-enhanced Ultrasound Imaging.
van Riel LAMJG; van Kollenburg RAA; Freund JE; Almasian M; Jager A; Engelbrecht MRW; Smit RS; Bekers E; Nieuwenhuijzen JA; van Leeuwen PJ; van der Poel H; de Reijke TM; Beerlage HP; Oddens JR; de Bruin DM
Eur Urol Open Sci; 2023 Aug; 54():72-79. PubMed ID: 37545846
[TBL] [Abstract][Full Text] [Related]
4. Safety and Feasibility of Soractelite Transperineal Focal Laser Ablation for Prostate Cancer and Short-term Quality of Life Analysis from a Multicenter Pilot Study.
van Riel LAMJG; van Kollenburg RAA; Vis AN; van Leeuwen PJ; de Reijke TM; de Bruin DM; Oddens JR
Eur Urol Open Sci; 2022 May; 39():48-54. PubMed ID: 35528781
[TBL] [Abstract][Full Text] [Related]
5. Oncological Outcome and Value of Postoperative Magnetic Resonance Imaging after Focal High-Intensity Focused Ultrasound Therapy for Prostate Cancer.
Rosenhammer B; Niessen C; Rotzinger L; Reiss J; Schnabel MJ; Burger M; Bründl J
Urol Int; 2019; 103(3):270-278. PubMed ID: 31466073
[TBL] [Abstract][Full Text] [Related]
6. Transperineal Laser Ablation Treatment for Lower Urinary Tract Symptoms Due to Benign Prostatic Obstruction: Protocol for a Prospective In Vivo Pilot Study.
van Kollenburg RAA; van Riel LAMJG; Bloemen PR; Oddens JR; de Reijke TM; Beerlage HP; de Bruin DM
JMIR Res Protoc; 2020 Jan; 9(1):e15687. PubMed ID: 31961326
[TBL] [Abstract][Full Text] [Related]
7. Salvage Magnetic Resonance Imaging-guided Transurethral Ultrasound Ablation for Localized Radiorecurrent Prostate Cancer: 12-Month Functional and Oncological Results.
Anttinen M; Mäkelä P; Viitala A; Nurminen P; Suomi V; Sainio T; Saunavaara J; Taimen P; Sequeiros RB; Boström PJ
Eur Urol Open Sci; 2020 Dec; 22():79-87. PubMed ID: 34337481
[TBL] [Abstract][Full Text] [Related]
8. Transperineal interstitial laser ablation of the prostate, a novel option for minimally invasive treatment of benign prostatic obstruction.
de Rienzo G; Lorusso A; Minafra P; Zingarelli M; Papapicco G; Lucarelli G; Battaglia M; Ditonno P
Eur Urol; 2021 Jul; 80(1):95-103. PubMed ID: 32868137
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of post-ablation mpMRI as a predictor of residual prostate cancer after focal high intensity focused ultrasound (HIFU) ablation.
Khandwala YS; Morisetty S; Ghanouni P; Fan RE; Soerensen SJC; Rusu M; Sonn GA
Urol Oncol; 2022 Nov; 40(11):489.e9-489.e17. PubMed ID: 36058811
[TBL] [Abstract][Full Text] [Related]
10. Focal Laser Ablation of Prostate Cancer: Feasibility of Magnetic Resonance Imaging-Ultrasound Fusion for Guidance.
Natarajan S; Jones TA; Priester AM; Geoghegan R; Lieu P; Delfin M; Felker E; Margolis DJA; Sisk A; Pantuck A; Grundfest W; Marks LS
J Urol; 2017 Oct; 198(4):839-847. PubMed ID: 28396184
[TBL] [Abstract][Full Text] [Related]
11. Feasibility of MR imaging/MR spectroscopy-planned focal partial salvage permanent prostate implant (PPI) for localized recurrence after initial PPI for prostate cancer.
Hsu CC; Hsu H; Pickett B; Crehange G; Hsu IC; Dea R; Weinberg V; Gottschalk AR; Kurhanewicz J; Shinohara K; Roach M
Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):370-7. PubMed ID: 22672747
[TBL] [Abstract][Full Text] [Related]
12. MRI-guided focal laser ablation of prostate cancer: a prospective single-arm, single-center trial with 3 years of follow-up.
Mehralivand S; George AK; Hoang AN; Rais-Bahrami S; Rastinehad AR; Lebastchi AH; Ahdoot M; Siddiqui MM; Bloom J; Sidana A; Merino MJ; Choyke PL; Shih JH; Turkbey B; Wood BJ; Pinto PA
Diagn Interv Radiol; 2021 May; 27(3):394-400. PubMed ID: 34003127
[TBL] [Abstract][Full Text] [Related]
13. The Design and Rationale of a Multicentre Randomised Controlled Trial Comparing Transperineal Percutaneous Laser Ablation With Transurethral Resection of the Prostate for Treating Benign Prostatic Hyperplasia.
Zhang W; Zhang W; Guo Q; Chen L; Meng Z; Xu Y; Cao N; Hu B; Qian B
Front Surg; 2021; 8():755957. PubMed ID: 34733883
[No Abstract] [Full Text] [Related]
14. Ultrasound-guided SoracteLite™ transperineal laser ablation (TPLA) of the prostate for the treatment of symptomatic benign prostatic hyperplasia (BPH): a prospective single-center experience.
Laganà A; Di Lascio G; Di Blasi A; Licari LC; Tufano A; Flammia RS; De Carolis A
World J Urol; 2023 Apr; 41(4):1157-1162. PubMed ID: 36853444
[TBL] [Abstract][Full Text] [Related]
15. Contrast enhanced ultrasound (CEUS) with MRI image fusion for monitoring focal therapy of prostate cancer with high intensity focused ultrasound (HIFU)1.
Apfelbeck M; Clevert DA; Ricke J; Stief C; Schlenker B
Clin Hemorheol Microcirc; 2018; 69(1-2):93-100. PubMed ID: 29660918
[TBL] [Abstract][Full Text] [Related]
16. MRI-Guided Ultrafocal Salvage High-Dose-Rate Brachytherapy for Localized Radiorecurrent Prostate Cancer: Updated Results of 50 Patients.
van Son MJ; Peters M; Moerland MA; Lagendijk JJW; Eppinga WSC; Shah TT; Ahmed HU; van der Voort van Zyp JRN
Int J Radiat Oncol Biol Phys; 2020 May; 107(1):126-135. PubMed ID: 32006609
[TBL] [Abstract][Full Text] [Related]
17. Medium-term Oncological Efficacy and Patient-reported Outcomes After Focal High-intensity Focused Ultrasound: The FOXPRO Trial.
Westhoff N; Ernst R; Kowalewski KF; Derigs F; Neuberger M; Nörenberg D; Popovic ZV; Ritter M; Stephan Michel M; von Hardenberg J
Eur Urol Focus; 2023 Mar; 9(2):283-290. PubMed ID: 36344395
[TBL] [Abstract][Full Text] [Related]
18. Utility of Multiparametric MRI for Predicting Residual Clinically Significant Prostate Cancer After Focal Laser Ablation.
Felker ER; Raman SS; Lu DSK; Tuttle M; Margolis DJ; ElKhoury FF; Sayre J; Marks LS
AJR Am J Roentgenol; 2019 Dec; 213(6):1253-1258. PubMed ID: 31361529
[No Abstract] [Full Text] [Related]
19. Prostate cancer treatment by the latest focal HIFU device with MRI/TRUS-fusion control biopsies: A prospective evaluation.
von Hardenberg J; Westhoff N; Baumunk D; Hausmann D; Martini T; Marx A; Porubsky S; Schostak M; Michel MS; Ritter M
Urol Oncol; 2018 Sep; 36(9):401.e1-401.e9. PubMed ID: 30093211
[TBL] [Abstract][Full Text] [Related]
20. 3-T MRI and clinical validation of ultrasound-guided transperineal laser ablation of benign prostatic hyperplasia.
Manenti G; Perretta T; Calcagni A; Ferrari D; Ryan CP; Fraioli F; Meucci R; Malizia A; Iacovelli V; Agrò EF; Floris R
Eur Radiol Exp; 2021 Sep; 5(1):41. PubMed ID: 34532768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
